Demographic and outcome data
| Characteristic | Group; median (range)* | p value | |
|---|---|---|---|
| HLAPD | OPD | ||
| No. of patients | 13 | 20 | |
| Age, yr | 69 (49–88) | 67 (33–78) | 0.45 |
| Sex, male:female, % | 85%:15% | 65%:35% | 0.26 |
| BMI | 24.2 (20.6–32.0) | 25.0 (16.4–33.3) | 0.87 |
| Charlson Comorbidity Index | 1 (0–4) | 2 (0–6) | 0.32 |
| ASA score | 2 (2–3) | 3 (2–3) | 0.36 |
| Operative time, min | 594 (407–779) | 553 (303–892) | 0.06 |
| Estimated blood loss, mL | 450 (100–4000) | 1000 (300–6500) | 0.023 |
| Intraoperative blood transfusion, no. (%) | 5 (38%) | 10 (50%) | 0.72 |
| Total 7-day analgesic use, mg IV, mean ± SD | 174 ± 117 | 288 ± 226 | 0.08 |
| Length of stay, d | 8 (6–14) | 12 (6–26) | 0.025 |
| 90-day mortality, no. (%) | 1 (8%) | 4 (20%) | 0.63 |
ASA = American Society of Anesthesiologists; BMI = body mass index; HLAPD = hybrid laparoscopy-assisted pancreaticoduodenectomy; IV = Intravenous; OPD = open pancreaticoduodenectomy; SD = standard deviation.
↵* Unless otherwise indicated.